Cipla Limited — Fexofenadine Exporter Profile
Indian Pharmaceutical Exporter · #3 for Fexofenadine · $13.6M export value · DGFT Verified
Cipla Limited is the #3 Indian exporter of Fexofenadine with $13.6M in export value and 921 verified shipments. Cipla Limited holds a 12.4% market share in Fexofenadine exports across 7 countries. The company exports 98 pharmaceutical products worth $1.1B across 26 therapeutic categories.
Cipla Limited — Fexofenadine Export Profile: Buyers & Destinations
Where Does Cipla Limited Export Fexofenadine?
| Country | Value | Shipments | Share |
|---|---|---|---|
| AUSTRALIA | $3.2M | 283 | 38.3% |
| UNITED KINGDOM | $2.5M | 256 | 30.7% |
| BELGIUM | $1.6M | 334 | 19.1% |
| SRI LANKA | $558.1K | 28 | 6.7% |
| GERMANY | $278.3K | 13 | 3.4% |
| POLAND | $135.3K | 5 | 1.6% |
| FINLAND | $8.3K | 2 | 0.1% |
Cipla Limited exports Fexofenadine to 7 countries. The largest destination is AUSTRALIA accounting for 38.3% of Cipla Limited's Fexofenadine shipments, followed by UNITED KINGDOM (30.7%) and BELGIUM (19.1%). These destinations reflect Cipla Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Fexofenadine from Cipla Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| NOUMED PHARMACEUTICALS PTY LTD | AUSTRALIA | $2.8M | 247 |
| ALLOGA UK LTD | UNITED KINGDOM | $2.4M | 227 |
| H.ESSERS & ZONEN INTERNATIONAL TRAN | BELGIUM | $810.3K | 166 |
| BREATHEFREE LANKA PVT LTD | SRI LANKA | $398.2K | 21 |
| FIEGE HEALTHCARE LOGISTICS GMBH | GERMANY | $246.7K | 11 |
| NOUMED PHARMACEUTICALS PTY LIMITED | AUSTRALIA | $204.0K | 28 |
| NOUMED PHARMACEUTICALS PTY LTD NOU | AUSTRALIA | $185.9K | 8 |
| H,ESSERS & ZONEN INTERNATIONAL TRAN | BELGIUM | $184.5K | 36 |
| BREATHEFREE LANKA PRIVATE LIMITED | SRI LANKA | $159.9K | 7 |
| H ESSERS ZONEN INTERNATIONAL TRAN | BELGIUM | $150.8K | 45 |
Cipla Limited supplies Fexofenadine to 22 buyers globally. The largest buyer is NOUMED PHARMACEUTICALS PTY LTD (AUSTRALIA), followed by ALLOGA UK LTD (UNITED KINGDOM) and H.ESSERS & ZONEN INTERNATIONAL TRAN (BELGIUM). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Fexofenadine Export Value and How Much Does Cipla Limited Contribute?
India exported $81.9M worth of Fexofenadine through 4,236 shipments from 224 suppliers to 97 countries, serving 599 buyers globally. Cipla Limited contributes $13.6M to this total, accounting for 12.4% of India's Fexofenadine exports. Cipla Limited ships Fexofenadine to 7 countries through 22 buyers.
What Is the Average Shipment Value for Cipla Limited's Fexofenadine Exports?
Cipla Limited's average Fexofenadine shipment value is $14.8K per consignment, based on 921 shipments totaling $13.6M. The largest destination is AUSTRALIA (38.3% of Cipla Limited's Fexofenadine exports).
How Does Cipla Limited Compare to Other Indian Fexofenadine Exporters?
Cipla Limited ranks #3 among 224 Indian Fexofenadine exporters with a 12.4% market share. The top 3 exporters are IND SWIFT LIMITED ($14.6M), CIPLA LIMITED ($13.6M), DR.REDDY'S LABORATORIES LTD ($12.4M). Cipla Limited processed 921 shipments to 7 destination countries.
What Fexofenadine Formulations Does Cipla Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| TERRY WHITE CHEMMART FEXOFENADINE HAYFEV | $916.6K | 72 |
| TREATHAY 120 MG FILM-COATED TABLETS (FEXOFENADINE 120MG) PACK SIZE 3 X 10'S | $263.6K | 15 |
| FEXOFENADINE HCL 180 MG TABLETS (INV.QTY | $159.1K | 22 |
| ALNODINE 180MG TABLETS (FEXOFENADINE) [P | $151.6K | 7 |
| TREATHAY 120 MG FILM-COATED TABLETS(FEXOFENADINE 120MG) PACK SIZE 3 X 10'S | $131.1K | 6 |
| FEXOFENADINE HYDROCHLORIDE 180 MG FILM- | $117.0K | 17 |
| FEXOFENADIN CIPLA (FEXOFENADINE HYDROCHL | $103.7K | 15 |
| FEXOFENADINE 180MG TABLETS PACK SIZE 3X10S | $100.4K | 3 |
| TREATHAY 120 MG FILM-COATED TABLETS (FEXOFENADINE 120MG) ( INV.QTY.134064 PACK 1 X 10'S = 1340640 NOS ) | $100.0K | 2 |
| TESCO HEALTH FEXOFENADINE HYDROCHLORIDE120MG FILM COATED TABLETS.(FEXOFENADINEHYDROCHLORIDE 120MG FILM COATED TABLETS) | $99.7K | 2 |
Cipla Limited exports 397 distinct Fexofenadine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is TERRY WHITE CHEMMART FEXOFENADINE HAYFEV with 72 shipments worth $916.6K.
Regulatory Requirements: Exporting Fexofenadine to Key Markets
What Cipla Limited must comply with to export Fexofenadine to its top destination countries
Australia — TGA
Approval Process
Registration on Australian Register of Therapeutic Goods (ARTG). Bioequivalence and quality data per TGA guidelines.
Timeline: 10–14 months
GMP & Export Requirements
TGA GMP clearance; PIC/S-aligned inspection. PIC/S certificate from India may expedite.
TGA sponsor licence for Australian importer; GMP clearance per manufacturing site
Note: TGA participates in PIC/S mutual recognition.
United Kingdom — MHRA
Approval Process
Post-Brexit UK Marketing Authorisation via national procedure. Separate from EU approval since January 2021.
Timeline: 12–15 months
GMP & Export Requirements
UK GMP compliance; MHRA inspection of manufacturing site
Manufacturer Import Authorisation (MIA) held by UK importer; Qualified Person (QP) batch release
Note: Post-Brexit: EU GMP certificates no longer automatically valid in UK. Separate MHRA recognition required.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Cipla Limited Compare to Nearest Fexofenadine Exporters?
Exporters ranked immediately above and below #3 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | IND SWIFT LIMITED | $14.6M | 524 | 12 | $27.8K |
| 3 | CIPLA LIMITED ★ | $13.6M | 921 | 7 | $14.8K |
| 4 | DR.REDDY'S LABORATORIES LTD | $12.4M | 249 | 5 | $50.0K |
| 1 | GRANULES INDIA LIMITED | $9.7M | 194 | 1 | $50.0K |
Cipla Limited ranks #3 among 224 Indian Fexofenadine exporters. Average shipment value of $14.8K compared to the market average of $365.5K. The closest competitors by value are IND SWIFT LIMITED and DR.REDDY'S LABORATORIES LTD.
Which Indian Ports Ship Fexofenadine Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 569 | 13.4% |
| JNPT/ NHAVA SHEVA SEA | 385 | 9.1% |
| SAHAR AIR CARGO ACC (INBOM4) | 362 | 8.5% |
| NHAVA SHEVA SEA (INNSA1) | 350 | 8.3% |
| HYDERABAD ICD | 229 | 5.4% |
| CHAWAPAYAL ICD | 186 | 4.4% |
| JNPT | 161 | 3.8% |
| CHAWAPAYAL ICD (INCPR6) | 142 | 3.4% |
Geopolitical & Trade Policy Impact on Cipla Limited's Fexofenadine Exports
Cipla's export operations are currently navigating a complex geopolitical landscape. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, resulting in increased freight costs and extended transit times. These challenges are particularly acute for time-sensitive pharmaceutical shipments, necessitating strategic adjustments in logistics and supply chain management.
In the United States, recent import policies, including the imposition of 100% tariffs on branded or patented pharmaceutical products effective October 2025, have introduced additional hurdles for Indian exporters. While generic drugs, a significant component of Cipla's portfolio, may be less affected, the overall trade environment demands vigilance and adaptability. Conversely, the India-European Union Free Trade Agreement, concluded in January 2026, offers a promising avenue for Cipla. The agreement aims to eliminate tariffs on pharmaceuticals, potentially enhancing Cipla's competitiveness in the European market and offsetting challenges faced in other regions.
Cipla Limited — Regulatory Compliance & Quality Standards
Maintaining stringent quality standards is paramount for Cipla, given the diverse regulatory environments across its export markets. The company has demonstrated a strong commitment to compliance, as evidenced by the U.S. Food and Drug Administration's (FDA) classification of its Bengaluru facility as Voluntary Action Indicated (VAI) in October 2025. This classification is crucial for sustaining and expanding Cipla's presence in the U.S. market. Additionally, the European Union's evolving regulatory framework, including the Falsified Medicines Directive, necessitates continuous adaptation to ensure compliance and maintain market access.
About Cipla Limited
Cipla Limited exports 98 products worth $1.1B. Beyond Fexofenadine, top products include Fluticasone, Amlodipine, Salbutamol, Telmisartan, Salmeterol. View the complete Cipla Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Fexofenadine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Fexofenadine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Cipla Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 921 individual customs records matching Cipla Limited exporting Fexofenadine, covering 397 formulations to 7 countries via 22 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 97+ countries, 599+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Fexofenadine Export Data from Cipla Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Cipla Limited's Fexofenadine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Cipla Limited
Full Company Profile →
98 products · $1.1B total trade · 26 categories
Fexofenadine Stats
Company Overview
Top Products by Cipla Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Cipla Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Fexofenadine. For current shipment-level data, contact TransData Nexus.